| BCLI Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the BCLI shares outstanding history going back to 8/4/2014:
Also see: BCLI Market Cap History BCLI YTD Return |
BCLI Shares Outstanding History — Brainstorm Cell Therapeutics Share Count Over Time
As of 5/11/2026 Brainstorm Cell Therapeutics has 11.03 million BCLI shares outstanding. Investors often track the BCLI shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows BCLI share count trends over time, with 50 historical shares outstanding datapoints presented, dating back to 8/4/2014.
| BCLI Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BCLI Historical Shares Outstanding: -2.66% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BCLI Stock Price Chart |
| About Brainstorm Cell Therapeutics Inc |
| BrainStorm Cell Therapeutics Inc. is a developer of autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. The neurodegenerative diseases include Amyotrophic Lateral Sclerosis (ALS), Progressive Multiple Sclerosis (PMS), Alzheimer's disease (AD), and others. Co. is engaged in the clinical development and commercialization of the NurOwn technology platform used to produce autologous mesenchymal stem cells- neurotrophic factors (MSC-NTF) cells. We show 50 historical shares outstanding datapoints in our coverage of BCLI's shares outstanding history. Understanding the changing numbers of BCLI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BCLI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BCLI by allowing them to research BCLI shares outstanding history as well as any other stock in our coverage universe. |
| BCLI Current Stock Quote |
Quotes delayed 20 minutes  Free BCLI Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| BCLI Share Performance |
| Shares Outstanding Peers |
| Brainstorm Cell Therapeutics (BCLI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
BCRX Shares Outstanding History BDSI Shares Outstanding History BDSX Shares Outstanding History BDTX Shares Outstanding History BDX Shares Outstanding History BEAM Shares Outstanding History BEAT Shares Outstanding History BFLY Shares Outstanding History BFRG Shares Outstanding History BFRI Shares Outstanding History More Healthcare companies » |
BCLI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
